Company

a vision...

...is growing

and becomes reality!

1994

Foundation of CellGenix as a spin-off from the University Medical Center Freiburg

1995

First European ELA/PLA for blood stem cells according to GMP and German Drug Law

1996

Joint venture with Schering AG (Berlin, Germany). Establishment of the Metreon Bioproducts GmbH

1997

First serum-free medium for hematopoietic stem cell expansion

1998

PLA for the processing of dendritic cells

1999

PLA for the production of chondrocytes. Marketing & Sales alliance with ORMED GmbH (Freiburg, Germany)

1999

1000th clinical blood stem cell preparation according to GMP and German Drug Law

2000

Acquisition of venture captital, strategic alliance with Afc Inc., (Gaithersburg USA) and establishment of US representation

2000

First serum-free medium for Dendritic Cell differentiation

2001

Opening of the new GMP facility complex at Freiburg airport

2001

PLA for the manufacturing of a patient-specific idiotype vaccine

2002

Marketing & Sales alliance with Geistlich AG (Wolhusen, Switzerland) Distribution and selling rights for chondrocytes in Switzerland to Geistlich

2003

Worldwide first serum-free chondrocytes cultivation process

2003

First FDA Drug Master File for Interleukin 4

2004

EMEA Orphan Drug designation for idiotype vaccine

2004

10 year anniversary

2006

Marketing & Sales alliance with Stryker GmbH (Duisburg, Germany). Distribution and selling rights for chondrocytes in Europe

2007

Product launch of the worldwide first IL-15 in GMP quality (for clinical ex vivo cell culture)

CellGenix Team 2004, 10th anniversary